These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8487055)

  • 1. Interleukin-2-induced thyroid dysfunction is correlated with treatment duration but not with tumor response.
    Kruit WH; Bolhuis RL; Goey SH; Jansen RL; Eggermont AM; Batchelor D; Schmitz PI; Stoter G
    J Clin Oncol; 1993 May; 11(5):921-4. PubMed ID: 8487055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid dysfunction can predict response to immunotherapy with interleukin-2 and interferon-2 alpha.
    Reid I; Sharpe I; McDevitt J; Maxwell W; Emmons R; Tanner WA; Monson JR
    Br J Cancer; 1991 Nov; 64(5):915-8. PubMed ID: 1931616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid Dysfunction in Patients with Metastatic Carcinoma Treated with Sunitinib: Is Thyroid Autoimmunity Involved?
    Pani F; Atzori F; Baghino G; Boi F; Tanca L; Ionta MT; Mariotti S
    Thyroid; 2015 Nov; 25(11):1255-61. PubMed ID: 26414109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low doses of subcutaneous interleukin-2 plus interferon-alpha do not induce thyroid function alterations in advanced renal cell carcinoma patients.
    Sartore-Bianchi A; Soriani A; Mattioni R; Vaglio A; Buzio C; Porta C
    Oncol Rep; 2004 Oct; 12(4):855-9. PubMed ID: 15375512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-2-induced thyroid dysfunction is correlated with treatment duration but not with tumor response.
    Vassilopoulou-Sellin R; Sella A
    J Clin Oncol; 1993 Aug; 11(8):1626. PubMed ID: 8336201
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypothyroidism during immunotherapy with interleukin-2 is associated with antithyroid antibodies and response to treatment.
    Weijl NI; Van der Harst D; Brand A; Kooy Y; Van Luxemburg S; Schroder J; Lentjes E; Van Rood JJ; Cleton FJ; Osanto S
    J Clin Oncol; 1993 Jul; 11(7):1376-83. PubMed ID: 8315436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence rate and risk factors for thyroid dysfunction during recombinant interleukin-2 therapy in advanced malignancies.
    Vialettes B; Guillerand MA; Viens P; Stoppa AM; Baume D; Sauvan R; Pasquier J; San Marco M; Olive D; Maraninchi D
    Acta Endocrinol (Copenh); 1993 Jul; 129(1):31-8. PubMed ID: 8351956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid functions in patients treated with interleukin-2 and lymphokine-activated killer cells.
    Kung AW; Lai CL; Wong KL; Tam CF
    Q J Med; 1992 Jan; 82(297):33-42. PubMed ID: 1332102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid dysfunction as an unintended side effect of anticancer drugs.
    Torino F; Barnabei A; Paragliola R; Baldelli R; Appetecchia M; Corsello SM
    Thyroid; 2013 Nov; 23(11):1345-66. PubMed ID: 23750887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical investigation of thyroid disorders.
    Miller JL
    S Afr Med J; 1981 Apr; 59(17):593-6. PubMed ID: 6784252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient stimulatory effects on pituitary-thyroid axis in patients treated with interleukin-2.
    Witzke O; Winterhagen T; Saller B; Roggenbuck U; Lehr I; Philipp T; Mann K; Reinhardt W
    Thyroid; 2001 Jul; 11(7):665-70. PubMed ID: 11484895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endocrine involvement in immunotherapy].
    Tartour E; Schlumberger M; Dorval T; Baudin E; Fridman WH
    Ann Endocrinol (Paris); 1995; 56(2):143-8. PubMed ID: 7755342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The odyssey of nontoxic nodular goiter (NTNG) in Greece under suppression therapy, and after improvement of iodine deficiency.
    Michalaki M; Kyriazopoulou V; Paraskevopoulou P; Vagenakis AG; Markou KB
    Thyroid; 2008 Jun; 18(6):641-5. PubMed ID: 18578614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid dysfunction in 281 patients with metastatic melanoma or renal carcinoma treated with interleukin-2 alone.
    Krouse RS; Royal RE; Heywood G; Weintraub BD; White DE; Steinberg SM; Rosenberg SA; Schwartzentruber DJ
    J Immunother Emphasis Tumor Immunol; 1995 Nov; 18(4):272-8. PubMed ID: 8680655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thyroid antibodies in autoimmune diseases of the thyroid and their dependence on the presence of autoantigens].
    Kriukova IV; Bazarova EN; Biriukova MP; Konnova EV; Okeanova TA
    Probl Endokrinol (Mosk); 1989; 35(4):19-22. PubMed ID: 2602346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of various doses of recombinant human thyrotropin on the thyroid radioactive iodine uptake and serum levels of thyroid hormones and thyroglobulin in normal subjects.
    Torres MS; Ramirez L; Simkin PH; Braverman LE; Emerson CH
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1660-4. PubMed ID: 11297600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of thyroid dysfunction and influencing factors in chronic hepatitis C patients treated with peg-IFNa-2a and ribavirin].
    Huang YX; Chen XY; Ma LN; Yin JM; Ren S; Guo DD; Zheng YH
    Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):216-20. PubMed ID: 22475143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postpartum thyroid dysfunction in women with autoimmune thyroiditis.
    Argatska A; Nonchev B; Orbetzova M; Pehlivanov B
    Gynecol Endocrinol; 2016; 32(5):379-82. PubMed ID: 26669901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma.
    Phan GQ; Attia P; Steinberg SM; White DE; Rosenberg SA
    J Clin Oncol; 2001 Aug; 19(15):3477-82. PubMed ID: 11481353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organochlorine pesticide exposure and thyroid function: a study in human subjects.
    Srivastava AK; Gupta BN; Bihari V; Mathur N; Pangtey BS; Bharti RS; Godbole MM
    J Environ Pathol Toxicol Oncol; 1995; 14(2):107-10. PubMed ID: 9372839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.